am 580 has been researched along with Chromosomal Translocation in 1 studies
Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benedetti, L | 1 |
Grignani, F | 1 |
Scicchitano, BM | 1 |
Jetten, AM | 1 |
Diverio, D | 1 |
Lo Coco, F | 1 |
Avvisati, G | 1 |
Gambacorti-Passerini, C | 1 |
Adamo, S | 1 |
Levin, AA | 1 |
Pelicci, PG | 1 |
Nervi, C | 1 |
1 other study available for am 580 and Chromosomal Translocation
Article | Year |
---|---|
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Topics: Apoptosis; Benzoates; CD18 Antigens; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, | 1996 |